xencor.com - XNCR Income before deduction of interest, taxes and amortization

Graphic logo of Xencor Inc (XNCR)

Xencor, Inc. (XNCR) maintains experienced management that effectively oversees R&D, as evidenced by the company's operating result before depreciation, where the latest parameter stands at 0.00. The business is based on creating protein platforms to combat cancer in collaboration with pharma behemoths. Cost optimization is achieved through extensive outsourcing of clinical trials and manufacturing, allowing the company to focus on innovative research.

Profit before payment of interest, taxes and amortization: Xencor, Inc. (XNCR) for 11/23/2025 - 11/12/2026

Xencor - analytical breakdowns and key metrics (XNCR)

- market value and analyst target forecast:
Market Price Xencor Inc.|XNCR - Consensus Target
- issuer market value details:
Market Value Xencor|XNCR - Enterprise Value
- book capitalization information:
Net Assets per Share Xencor|XNCR - Company Book Value|Market Cap to Net Assets Ratio xencor.com|XNCR - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Xencor, Inc.|XNCR - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Xencor Inc|XNCR - Company Debts|Debt to Book Value Ratio Xencor|XNCR - Company Long-Term Debt|Short-Term Debt Xencor|Critical Liquidity xencor.com
- company profitability and valuation multiples indicators:
XNCR - Net Income|Future Net Profit Xencor, Inc.|XNCR - P/E Multiple|Future Price to Earnings Multiple xencor.com|XNCR - PEG Multiple|Company Value to EBITDA Xencor|XNCR - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Xencor|XNCR - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth xencor.com|XNCR - Earnings per share growth in current year|Net earnings per share change forecast for next year Xencor, Inc.
Analysis of all company metrics:Xencor Inc. - XNCR
Mass-produced product of Xencor

This indicator reflects the actual cash flow from core operations, excluding the impact of non-cash accounting write-downs. The trend in calculated EBITDA allows for an objective assessment of operating efficiency without reporting distortions. The metric aggregates earnings before interest, taxes, depreciation, and amortization. For Xencor, Inc. (XNCR), this is a critical marker of the stability of licensing revenues from partners. Such control mitigates risks associated with the development costs of its own oncology drugs.

Competitors of Xencor, Inc. (XNCR)

NantKwest (IBRX) - Profit before interest, taxes and amortization|IMCR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization JANX (januxrx.com)|RCUS: Operating profit EBITDA|ZYME - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Tango Pharma|Operating profit before deduction of amortization Iovance Corp (IOVA)|Profit before payment of interest, taxes and amortization Immatics N.V. (IMTX)|Operating profit before deduction of amortization compasstherapeutics.com CMPX|Replimune - Operating profit before deduction of amortization|Operating profit EBITDA Lyell LYEL|IPHA - Profit before payment of interest, taxes and amortization|PYXS (Pyxis Oncology, Inc.) - Operating profit before amortization|cgen.com (CGEN) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization iobiotech.com (IOBT)|Operating profit before deduction of amortization STRO|INKT - Operating profit before depreciation charges|Operating profit before deduction of amortization HOWL (Werewolf Therapeutics)|Company profit before taxes, interest and amortization IMMX|Operating profit EBITDA ALXO (ALX Oncology)|Income before deduction of interest, taxes and amortization CUE|PDS Biotechnology Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Sonnet BioTherapeutics|MAIA Biotechnology Inc (MAIA) - Profit before payment of interest, taxes and amortization|Liminatus - Income before deduction of interest, taxes and amortization|LVTX (LAVA Therapeutics NV) - Operating profit EBITDA|Operating profit EBITDA nextcure.com|Profit before payment of interest, taxes and amortization Leap Therapeutics, Inc. (LPTX)|INTS: Profit before deduction of interest, taxes, depreciation and amortization|Sensei Biotherapeutics, Inc. - Operating profit before deduction of amortization|Theriva Corp (TOVX) - Profit before interest, taxes and amortization|GRTS: Operating profit before deduction of amortization|KA (kinetabio.com) - Operating profit before amortization|NEXI: Operating profit EBITDA|Profit before interest, taxes and amortization Turnstone Biologics Corp. (TSBX)|Profit before payment of interest, taxes and amortization Vaccinex, Inc|Operating profit before amortization HARP (Harpoon Therapeutics Corp)